• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Richard Gaynor - Articles and news items

Updates on three of six ongoing Phase III Ramucirumab trials to be presented

Industry news, News / 14 May 2012 / Eli Lilly and Company

Eli Lilly and Company will present data from several molecules…

Lilly targets faulty c-MET receptor in cancer research studies presented at AACR Meeting

Industry news, News / 2 April 2012 / Eli Lilly and Company

Studies provided basis for ongoing Phase I, II studies in gastric, other cancers…

Lilly oncology reveals findings from study of JAK2 inhibitor for blood cancers at ASH meeting

Industry news, News / 12 December 2011 / Eli Lilly and Company

Data from an oncology pipeline molecule announced at the ASH meeting…